The CEO told the bank in a letter that his condition was curable.
(Reporting by Sinchita Mitra in Bengaluru; Editing by Sherry Jacob-Phillips)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
202.4 GBX | +0.67% | -0.98% | +31.58% |
04/05 | Norway wealth fund to back Barclays CEO, chair at AGM | RE |
04/05 | NORWAY SOVEREIGN WEALTH FUND: SUPPORTS REAPPOINTMENTS OF BARCLAY… | RE |
(Reuters) - British bank Barclays PLC said on Monday its chief executive officer C.S. Venkatakrishnan would be undergoing treatment for non-hodgkin's lymphoma, a type of cancer, and that this would mean he would work from home for some periods.
The CEO told the bank in a letter that his condition was curable.
(Reporting by Sinchita Mitra in Bengaluru; Editing by Sherry Jacob-Phillips)
1st Jan change | Capi. | |
---|---|---|
+31.58% | 38.03B | |
+12.00% | 547B | |
+10.60% | 291B | |
+12.04% | 250B | |
+21.78% | 210B | |
+17.11% | 171B | |
+11.40% | 169B | |
+11.01% | 164B | |
+3.27% | 143B | |
-11.10% | 139B |